|
XTant Medical Holdings, Inc. (XTNT) Évaluation DCF |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Xtant Medical Holdings, Inc. (XTNT) Bundle
Gardez un aperçu de votre analyse d'évaluation XTant Medical Holdings, Inc. (XTNT) avec notre puissant calculatrice DCF! Préchargé avec des données XTNT réelles, ce modèle Excel vous permet d'ajuster les prévisions et les hypothèses pour déterminer avec précision la valeur intrinsèque de XTant Medical Holdings, Inc. (XTNT).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53.3 | 55.3 | 58.0 | 91.3 | 117.3 | 145.0 | 179.2 | 221.5 | 273.8 | 338.4 |
| Revenue Growth, % | 0 | 3.61 | 4.9 | 57.5 | 28.44 | 23.61 | 23.61 | 23.61 | 23.61 | 23.61 |
| EBITDA | 1.3 | -2.5 | -5.4 | 5.1 | -7.9 | -3.6 | -4.5 | -5.6 | -6.9 | -8.5 |
| EBITDA, % | 2.49 | -4.55 | -9.36 | 5.56 | -6.72 | -2.52 | -2.52 | -2.52 | -2.52 | -2.52 |
| Depreciation | 2.1 | 1.3 | 1.3 | 3.2 | 4.2 | 4.5 | 5.6 | 6.9 | 8.6 | 10.6 |
| Depreciation, % | 3.9 | 2.43 | 2.24 | 3.48 | 3.6 | 3.13 | 3.13 | 3.13 | 3.13 | 3.13 |
| EBIT | -.8 | -3.9 | -6.7 | 1.9 | -12.1 | -8.2 | -10.1 | -12.5 | -15.5 | -19.1 |
| EBIT, % | -1.41 | -6.97 | -11.6 | 2.08 | -10.32 | -5.64 | -5.64 | -5.64 | -5.64 | -5.64 |
| Total Cash | 2.3 | 18.2 | 20.3 | 5.7 | 6.2 | 24.3 | 30.1 | 37.2 | 46.0 | 56.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6.9 | 7.2 | 10.9 | 20.7 | 20.7 | 24.6 | 30.4 | 37.6 | 46.5 | 57.5 |
| Account Receivables, % | 12.9 | 12.95 | 18.72 | 22.71 | 17.62 | 16.98 | 16.98 | 16.98 | 16.98 | 16.98 |
| Inventories | 21.4 | 17.9 | 17.3 | 36.9 | 38.6 | 51.0 | 63.0 | 77.9 | 96.2 | 119.0 |
| Inventories, % | 40.14 | 32.47 | 29.82 | 40.4 | 32.95 | 35.15 | 35.15 | 35.15 | 35.15 | 35.15 |
| Accounts Payable | 2.3 | 2.6 | 3.5 | 7.1 | 7.9 | 8.6 | 10.6 | 13.1 | 16.2 | 20.0 |
| Accounts Payable, % | 4.29 | 4.73 | 6.02 | 7.73 | 6.75 | 5.9 | 5.9 | 5.9 | 5.9 | 5.9 |
| Capital Expenditure | -1.5 | -2.1 | -1.8 | -1.5 | -4.1 | -4.3 | -5.3 | -6.6 | -8.1 | -10.1 |
| Capital Expenditure, % | -2.9 | -3.83 | -3.04 | -1.59 | -3.51 | -2.97 | -2.97 | -2.97 | -2.97 | -2.97 |
| Tax Rate, % | -1.15 | -1.15 | -1.15 | -1.15 | -1.15 | -1.15 | -1.15 | -1.15 | -1.15 | -1.15 |
| EBITAT | -.8 | -3.9 | -6.8 | -1.2 | -12.2 | -6.5 | -8.1 | -10.0 | -12.4 | -15.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -26.2 | -1.1 | -9.4 | -25.4 | -12.9 | -22.0 | -23.6 | -29.2 | -36.1 | -44.6 |
| WACC, % | 6.77 | 6.77 | 6.77 | 3.34 | 6.77 | 6.08 | 6.08 | 6.08 | 6.08 | 6.08 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -127.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -46 | |||||||||
| Terminal Value | -1,115 | |||||||||
| Present Terminal Value | -830 | |||||||||
| Enterprise Value | -958 | |||||||||
| Net Debt | 29 | |||||||||
| Equity Value | -987 | |||||||||
| Diluted Shares Outstanding, MM | 134 | |||||||||
| Equity Value Per Share | -7.38 |
What You Will Get
- Real XTNT Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess Xtant Medical's future performance.
- User-Friendly Design: Designed for professionals while remaining accessible to novices.
Key Features
- 🔍 Real-Life XTNT Financials: Pre-filled historical and projected data for Xtant Medical Holdings, Inc. (XTNT).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Xtant's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Xtant's valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for Xtant Medical Holdings, Inc. (XTNT).
- Step 2: Review the pre-filled financial data and forecasts specific to Xtant Medical.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Xtant Medical Holdings, Inc. (XTNT)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses specifically for XTNT.
- Flexible Inputs: Modify yellow-highlighted cells to explore different financial scenarios for Xtant Medical.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Xtant Medical Holdings, Inc. (XTNT).
- Preloaded Information: Historical and projected data provide a solid foundation for analysis.
- Expert-Level Tool: Perfect for financial analysts, investors, and consultants focused on the healthcare sector.
Who Should Use This Product?
- Investors: Evaluate Xtant Medical's valuation prior to making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess future projections.
- Startup Founders: Understand the valuation strategies of established medical companies like Xtant Medical.
- Consultants: Provide clients with comprehensive valuation reports for informed decision-making.
- Students and Educators: Utilize real data from Xtant Medical to enhance learning and practice in valuation techniques.
What the Template Contains
- Preloaded XTNT Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.